| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3391684 | Seminars in Immunology | 2008 | 7 Pages |
Abstract
The choice of antigens to be used in cancer immunotherapy remains a crucial and difficult issue. This review highlights some properties of the different groups of human tumor antigens recognized by T lymphocytes, focusing on parameters that should influence this choice, such as tumor specificity and level of antigen expression.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
S. Lucas, P.G. Coulie,